Literature DB >> 19337833

A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity.

Douglas A Drossman1, Lin Chang, Susan Schneck, Carlar Blackman, William F Norton, Nancy J Norton.   

Abstract

There is a growing need to understand from the patient's perspective the experience of irritable bowel syndrome (IBS) and the factors contributing to its severity; this has been endorsed by the Food and Drug Administration (FDA). Accordingly, we conducted focus groups to address this issue. A total of 32 patients with mostly moderate to severe IBS were recruited through advertising and were allocated into three focus groups based on predominant stool pattern. The focus groups were held using standard methodology to obtain a general assessment of the symptoms experienced with IBS, its impact, and of factors associated with self-perceived severity. Patients described IBS not only as symptoms (predominantly abdominal pain) but mainly as it affects daily function, thoughts, feelings and behaviors. Common responses included uncertainty and unpredictability with loss of freedom, spontaneity and social contacts, as well as feelings of fearfulness, shame, and embarrassment. This could lead to behavioral responses including avoidance of activities and many adaptations in routine in an effort for patients to gain control. A predominant theme was a sense of stigma experienced because of a lack of understanding by family, friends and physicians of the effects of IBS on the individual, or the legitimacy of the individual's emotions and adaptation behaviors experienced. This was a barrier to normal functioning that could be ameliorated through identifying with others who could understand this situation. Severity was linked to health-related quality of life (HRQOL) and was influenced by the intensity of abdominal pain and other symptoms, interference with and restrictions relating to eating, work, and social activities, and of the unpredictability of the condition. This study confirms the heterogeneous and multi-component nature of IBS. These qualitative data can be used in developing health status and severity instruments for larger-scale studies.

Entities:  

Mesh:

Year:  2009        PMID: 19337833     DOI: 10.1007/s10620-009-0792-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  The patient's perspective of irritable bowel syndrome.

Authors:  S Bertram; M Kurland; E Lydick; G R Locke; B P Yawn
Journal:  J Fam Pract       Date:  2001-06       Impact factor: 0.493

2.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

3.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 4.  Health status in inflammatory bowel disease. Biological and behavioral considerations.

Authors:  J W Garrett; D A Drossman
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

5.  Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

Authors:  D A Drossman; D L Patrick; W E Whitehead; B B Toner; N E Diamant; Y Hu; H Jia; S I Bangdiwala
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

Review 6.  Irritable bowel syndrome: toward an understanding of severity.

Authors:  Anthony Lembo; Vanessa Z Ameen; Douglas A Drossman
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

7.  International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Authors:  Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

8.  The rating form of IBD patient concerns: a new measure of health status.

Authors:  D A Drossman; J Leserman; Z M Li; C M Mitchell; E A Zagami; D L Patrick
Journal:  Psychosom Med       Date:  1991 Nov-Dec       Impact factor: 4.312

9.  Functional bowel disorders. A multicenter comparison of health status and development of illness severity index.

Authors:  D A Drossman; Z Li; B B Toner; N E Diamant; F H Creed; D Thompson; N W Read; C Babbs; M Barreiro; L Bank
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

10.  Incorporating patients' views and experiences of life with IBS in the development of an evidence based self-help guidebook.

Authors:  Anne Kennedy; Andrew Robinson; Anne Rogers
Journal:  Patient Educ Couns       Date:  2003-07
View more
  31 in total

Review 1.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

2.  Understanding gastrointestinal distress: a framework for clinical practice.

Authors:  Brennan M R Spiegel; Dinesh Khanna; Roger Bolus; Nikhil Agarwal; Puja Khanna; Lin Chang
Journal:  Am J Gastroenterol       Date:  2011-03       Impact factor: 10.864

Review 3.  Psychosocial determinants of irritable bowel syndrome.

Authors:  Teodora Surdea-Blaga; Adriana Băban; Dan L Dumitrascu
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

4.  Validation of the Health-Related Felt Stigma and Concealment Questionnaire.

Authors:  Kelsey T Laird; Craig A Smith; Steven D Hollon; Lynn S Walker
Journal:  J Pediatr Psychol       Date:  2020-06-01

Review 5.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

6.  Perceived stereotyping and seeking care for chronic vulvar pain.

Authors:  Ruby H N Nguyen; Rachael M Turner; Sarah A Rydell; Richard F Maclehose; Bernard L Harlow
Journal:  Pain Med       Date:  2013-06-06       Impact factor: 3.750

7.  Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.

Authors:  Raymond Addante; Bruce Naliboff; Wendy Shih; Angela P Presson; Kirsten Tillisch; Emeran A Mayer; Lin Chang
Journal:  J Clin Gastroenterol       Date:  2019-04       Impact factor: 3.062

Review 8.  The global impact of IBS: time to think about IBS-specific models of care?

Authors:  Maura Corsetti; Peter Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2017-07-31       Impact factor: 4.409

Review 9.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

10.  Does a brief state mindfulness induction moderate disgust-driven social avoidance and decision-making? An experimental investigation.

Authors:  Lisa M Reynolds; Yee Sing Lin; Eric Zhou; Nathan S Consedine
Journal:  J Behav Med       Date:  2014-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.